Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 64,625 | 66,889 | 69,700 | 61,980 | 60,651 |
| Cost of Goods | 31,963 | 32,364 | 33,211 | 31,051 | 24,642 |
| Gross Profit | 32,662 | 34,525 | 36,489 | 30,929 | 36,009 |
| Operating Expenses | 42,408 | 43,859 | 41,538 | 47,960 | 46,011 |
| Operating Income | -8,783 | -8,970 | -4,838 | -16,980 | -9,360 |
| Interest Expense | 157 | 81 | 388 | 348 | 88 |
| Other Income | -68 | 1,934 | 699 | 87 | 647 |
| Pre-tax Income | -9,008 | -7,117 | -4,527 | -17,241 | -8,801 |
| Income Tax | 121 | 163 | 162 | 269 | 14,413 |
| Net Income Continuous | -9,129 | -7,280 | -4,689 | -17,510 | -23,214 |
| Net Income | $-9,129 | $-7,280 | $-4,689 | $-17,510 | $-23,214 |
| EPS Basic Total Ops | -4,407.93 | -3,560.34 | -2,297.00 | -8,728.58 | -11,484.97 |
| EPS Basic Continuous Ops | -4,379.80 | -3,505.25 | -2,294.35 | -8,724.21 | -11,501.32 |
| EPS Diluted Total Ops | -4,407.93 | -3,560.34 | -2,297.00 | -8,728.58 | -11,484.97 |
| EPS Diluted Continuous Ops | -4,379.80 | -3,505.25 | -2,294.35 | -8,724.21 | -11,501.32 |
| EBITDA(a) | $-6,874 | $-7,075 | $-2,537 | $-15,747 | $-8,664 |